Exemplification of the challenges associated with utilising fluorescence intensity based assays in discovery. - Wikidata - wikimedia - TriplyDB

Exemplification of the challenges associated with utilising fluorescence intensity based assays in discovery.

Exemplification of the challenges associated with utilising fluorescence intensity based assays in discovery.

http://www.wikidata.org/entity/Q38028561

about

Discovery and resupply of pharmacologically active plant-derived natural products: A review A small molecule antagonist of ghrelin O-acyltransferase (GOAT).A bioluminogenic HDAC activity assay: validation and screening.PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.Identification of Small-Molecule Frequent Hitters from AlphaScreen High-Throughput Screens.Post-HTS case report and structural alert: Promiscuous 4-aroyl-1,5-disubstituted-3-hydroxy-2H-pyrrol-2-one actives verified by ALARM NMR.Matching the power of high throughput screening to the chemical diversity of natural products Natural products for human health: an historical overview of the drug discovery approaches.

P2860

Q22252341-5F153C9B-B471-4D4B-9C27-FEE85628D791 Q33905436-7714CC8F-8E6E-44B1-95EC-3B611E0D93B2 Q33989826-F84A247E-5E9C-4940-8C75-57DC733D4CA6 Q34460371-7CB7EF24-84FD-4591-A9F9-FCCBB3FDACAE Q35076509-7813378C-3D74-4554-94A0-A289C12DF28E Q35759485-6369B30E-3996-406F-B279-1E8269E11280 Q37240957-251D89EF-8CBC-4CDE-8A50-1924AFC5483A Q38651171-12C38BD3-FA1A-4E9A-9424-CDEFBA163544

P2860

Exemplification of the challenges associated with utilising fluorescence intensity based assays in discovery.

http://www.wikidata.org/entity/Q38028561

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Exemplification of the challen ...... ity based assays in discovery.

@en

type

label

Exemplification of the challen ...... ity based assays in discovery.

@en

prefLabel

Exemplification of the challen ...... ity based assays in discovery.

@en

P1433

Q38028561-D1D2E2A5-77BB-4711-9BCB-F48C0FC3EDD9

P1476

Q38028561-3076D149-AC5C-4F5E-ACBD-D533A95EC458

P2093

Q38028561-91F8EAC2-5858-4345-86FA-8147C4F10D5A

Q38028561-FD0E1193-A297-4948-B4F2-86AC82FC3FF2

P2860

Q38028561-069CB14B-0C0D-4C0B-8652-B77C9C046712

Q38028561-06B6FE49-02A1-44FF-B568-4A164CC28082

Q38028561-0B311B64-8328-49EC-A789-1AA460031F5A

Q38028561-0DA3DB5F-B567-467E-BD4F-40CAE62C1E1F

Q38028561-0F124A5B-87C0-4748-8394-B16D03958203

Q38028561-28436BD5-DA36-4CF1-9F64-F7F97B9A8469

Q38028561-3C147360-CA1D-4087-B92F-445C0B5CE7FA

Q38028561-419D0D1F-DC98-4543-82B4-5C70A1C3766B

Q38028561-447BDF5C-CF2A-4ACF-9193-F86EBF64838E

Q38028561-45261867-7832-40A9-A9F5-538CDE5FE57E

P304

Q38028561-3B1C01D9-4FDA-43C2-BC12-0F94B9F79B05

P31

Q38028561-5A41F30B-C481-483A-AFD6-373AD623070C

P356

Q38028561-94707AB6-4247-4754-AA51-A5DE87C374D7

P407

Q38028561-0C0E68C4-CA36-4545-A73F-7820AACC2B35

P433

Q38028561-78BEEFF7-E02C-4C11-BE1A-19E1EE3ED5A7

P478

Q38028561-36C02AB3-52F1-479B-A8AA-B64A67CCFD65

P577

Q38028561-F1F1863F-1B6A-4C43-9489-00439AE48743

P698

Q38028561-94ECBD4E-BDFD-42B3-AC18-20DC4CCC320E

P356

17460441.2010.495748

P1433

Expert Opinion on Drug Discovery

P1476

Exemplification of the challen ...... ity based assays in discovery.

@en

P2093

Philip Gribbon

http://www.w3.org/2001/XMLSchema#string

Sheraz Gul

http://www.w3.org/2001/XMLSchema#string

P2860

Functional characterization of Narc 1, a novel proteinase related to proteinase K

Fas-mediated apoptosis is regulated by the extracellular matrix protein CCN1 (CYR61) in vitro and in vivo

SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

Bright ideas for chemical biology

Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia

Structural and biochemical characterization of the wild type PCSK9-EGF(AB) complex and natural familial hypercholesterolemia mutants

Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors

On the size of the active site in proteases. I. Papain

Oncogenic kinase signalling

P304

681-690

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17460441.2010.495748

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22823207

http://www.w3.org/2001/XMLSchema#string